Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

SomaLogic, Inc. (SLGCW)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.4006-0.0229 (-5.41%)
At close: 12:24PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.4235
Open3.0800
Bid2.3400 x 1000
Ask5.6200 x 1000
Day's Range0.3945 - 0.5240
52 Week Range0.3945 - 0.5240
Volume1,121
Avg. VolumeN/A
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    SomaLogic's Chief Medical Officer Steve Williams honored with C-Suite Award by the Denver Business Journal

    BOULDER, Colo., Sept. 26, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced that Chief Medical Officer Steve Williams, M.D., Ph.D., has been named a 2022 C-Suite Award winner by the Denver Business Journal. The honorees in the Denver Business Journal's 2022 C-Suite Awards program are executives who were evaluated by a team of third-party judges on the impact they have made on their organizations, industries and the greater commun

  • GlobeNewswire

    SomaLogic to Present at the Capital One Spatial Biology & Proteomics Summit

    BOULDER, Colo., Sept. 14, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that management will be participating in the upcoming Capital One Spatial Biology & Proteomics Summit taking place virtually on Wednesday, September 28. Roy Smythe, M.D, SomaLogic’s Chief Executive Officer is scheduled to participate in two panel discussions. Proteomics “Everything You Wanted to Know, But Were Afraid to Ask”Executive Panel Discussion at 10:15 a.m.

  • GlobeNewswire

    SomaLogic to Present at Morgan Stanley 20th Annual Global Healthcare Conference

    BOULDER, Colo., Aug. 31, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the upcoming Morgan Stanley 20th Annual Global Healthcare Conference in New York, New York. Roy Smythe, M.D, SomaLogic’s Chief Executive Officer is scheduled to participate in a fireside chat on Wednesday, September 14, 2022 at 12:20 p.m. Eastern Time. Interested parties may access a live and archived webcast of the present

Advertisement
Advertisement